The thicker, and potentially stiffer, sclera can lead to overestimation of intraocular pressure (IOP) and potential misdiagnosis of glaucoma. Patients with acromegaly have significantly thicker ...
Early tacrolimus + prednisolone + nintedanib therapy markedly improved the forced vital capacity decline slope from –20.9% to +11.2% per year in untreated PPF. Initiating combination therapy with ...
The prevalence of type 2 diabetes in patients with autoimmune liver disease was 27.6%. Type 2 diabetes seems to reduce the risk of primary sclerosing cholangitis (PSC), and primary biliary cholangitis ...
Early recognition of acromegalic features can expedite diagnosis and reduce heart failure risk. Timely surgical resection of a growth hormone-secreting pituitary adenoma, combined with ...
Oral infigratinib demonstrated the first statistically significant improvement in body proportionality in a randomized achondroplasia trial. BridgeBio Pharma reported positive topline results from ...
Three of the 4 patients with hereditary transthyretin amyloidosis (ATTR) and a negative bone scintigraphy had cardiac carbon-11-labeled Pittsburgh compound B uptake. Cardiomyopathy could be detected ...
Interim biomarker data from the first 4 patients showed lower creatine kinase levels by week 10, with 3 of the 4 also showing Glc4 reductions. Aro Biotherapeutics announced positive interim results ...
Prompt discontinuation of the suspected drug is critical for recovery. Drug-induced immune hemolytic anemia (DIIHA) should be investigated in suspected cases of warm autoimmune hemolytic anemia (warm ...
HDFN can cause adverse outcomes both prenatally and postnatally. Hemolytic disease of the fetus and newborn (HDFN) can be associated with both severe pre- and postnatal outcomes, according to a study ...
Key outcomes included high ILD prevalence, postmyopathic PPF in 13.5% of the cohort, higher rates of rapidly progressive ILD and transplantation in postmyopathic PPF, greater rituximab use in PPF, and ...
New research suggests that caffeine could help treat fatigue, among the most troubling symptoms of multiple sclerosis (MS). According to the results of a small study published in the February 2026 ...
The updated AABB/ICTMG guideline hopes to decrease excessive platelet transfusions. The adoption of an updated, more restrictive 2025 Association for the Advancement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results